Rosette Inhibitory Factor: T‐Lymphocyte Subpopulation Specificity and Potential Immunoregulatory Role in Hepatitis B Virus Infection
Gary Sanders, Robert P. Perrillo – 1 September 1982 – We have observed the disappearance of rosette inhibitory factor (RIF) from the serum of 19 patients with acute hepatitis B virus infection. This occurred at a time coinciding with the detection of anti‐HBs. In addition, levels of RIF activity were significantly greater (p < 0.001) in 35 HBsAg carriers who lacked anti‐HBs when compared to 15 carriers who regularly demonstrated this antibody. In all instances, RIF effect was partial affecting some, but not all, T‐lymphocytes from forming erythrocyte rosettes.